Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
ELOX was delisted on the 13th of October, 2023.
37 hedge funds and large institutions have $28.6M invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 4 closing their positions.
8% less funds holding
Funds holding: 40 → 37 (-3)
17% less capital invested
Capital invested by funds: $34.4M → $28.6M (-$5.76M)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$105K |
| 2 |
BlackRock
New York
|
+$97.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$91.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.6K |
| 5 |
Barclays
London,
United Kingdom
|
+$52.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$158K |
| 2 |
Morgan Stanley
New York
|
-$117K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$114K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$94.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$54K |
ELOX Hedge Fund Activity: Q1 2021 in Review
37 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q1 2021, worth a combined $28.6M — down 17% from $34.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ELOX and 1 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 9 added.
The largest buyer was Bank of America, adding an estimated $105K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $158K sold.
- 37 institutional investors held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q1 2021, down from 40 in Q4 2020.
- Funds reported $28.6M of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q1 2021, down 17% quarter-over-quarter.
- 1 fund opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 4 closed out, a net change of -3 holders.
- The largest Eloxx Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was Bank of America, an estimated $105K added.
- The largest Eloxx Pharmaceuticals, Inc. Common Stock seller in Q1 2021 was Renaissance Technologies, an estimated $158K sold.
Based on aggregated 13F filings for Q1 2021.